Provided by Tiger Trade Technology Pte. Ltd.

Collegium Pharmaceutical

22.09
-0.0200-0.09%
Post-market: 21.27-0.8200-3.71%18:43 EDT
Volume:438.44K
Turnover:9.73M
Market Cap:719.15M
PE:17.39
High:22.40
Open:22.01
Low:21.77
Close:22.11
52wk High:50.79
52wk Low:21.43
Shares:32.56M
Float Shares:31.37M
Volume Ratio:0.61
T/O Rate:1.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.27
EPS(LYR):1.73
ROE:17.61%
ROA:5.75%
PB:2.31
PE(LYR):12.77

Loading ...

Collegium Pharmaceutical Outlook Supported by ADHD Trends, Low Generic Drug Risk, Oppenheimer Says

MT Newswires Live
·
20 hours ago

Collegium's Durable Cash Flow From Pain Portfolio Poised to Support Further Business Development, Oppenheimer Says

MT Newswires Live
·
Sep 23

Oppenheimer Initiates Collegium Pharmaceutical at Outperform With $50 Price Target

MT Newswires Live
·
Sep 23

US Research Roundup- Allstate, Autozone, Vertex Pharmaceuticals

Reuters
·
Sep 23

H.C. Wainwright Reaffirms Their Buy Rating on Collegium Pharmaceutical (COLL)

TIPRANKS
·
Sep 22

Leerink Partners Initiates Coverage on Collegium Pharmaceutical With Outperform Rating, $45 Price Target

MT Newswires Live
·
Sep 09

Truist Cuts Price Target on Collegium Pharmaceutical to $49 From $58, Keeps Buy Rating

MT Newswires Live
·
Sep 09

Analysts Offer Insights on Healthcare Companies: Collegium Pharmaceutical (COLL), Revolution Medicines (RVMD) and Intellia Therapeutics (NTLA)

TIPRANKS
·
Sep 09

Collegium Pharmaceutical, Inc. : Leerink Partners Initiates Coverage with Outperform Rating; Price Target $45

THOMSON REUTERS
·
Sep 09

Collegium Pharmaceutical assumed with a Buy at Truist

TIPRANKS
·
Sep 09

U.S. Research Roundup-Argan, Mastec, Oracle

Reuters
·
Sep 09

Collegium Pharmaceutical is Maintained at Overweight by Barclays

Dow Jones
·
Aug 19

Barclays Sticks to Their Buy Rating for Collegium Pharmaceutical (COLL)

TIPRANKS
·
Aug 19

Collegium Pharmaceutical Enters $50 Million Accelerated Share Repurchase Agreement

MT Newswires Live
·
Aug 13

Collegium Announces $50 Million Accelerated Share Repurchase Program

THOMSON REUTERS
·
Aug 13

Collegium Pharmaceutical Price Target Cut to $43.00/Share from $45.00 by Piper Sandler

Dow Jones
·
Aug 08

U.S. Research Roundup-Airbnb, Expedia Group, Parker-Hannifin

Reuters
·
Aug 07

Analysts’ Top Healthcare Picks: Collegium Pharmaceutical (COLL), Adicet Bio (ACET)

TIPRANKS
·
Aug 07

Collegium Pharmaceutical Down over 13%, on Track for Largest Percent Decrease Since May 2024

Dow Jones
·
Aug 06

Collegium Pharmaceutical Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06